Sentinel Lymph Node Biopsy vs. Observation in Thin Melanoma: A Multicenter Propensity Score Matching Study

The therapeutic value of sentinel lymph node biopsy (SLNB) in thin melanoma remains controversial. The aim of this study is to determine the role of SLNB in the survival of thin melanomas (≤1 mm). A multicenter retrospective observational study was designed. A propensity score matching was performed...

Full description

Bibliographic Details
Main Authors: Antonio Tejera-Vaquerizo, Aram Boada, Simone Ribero, Susana Puig, Sabela Paradela, David Moreno-Ramírez, Javier Cañueto, Blanca de Unamuno-Bustos, Ana Brinca, Miguel A. Descalzo-Gallego, Simona Osella-Abate, Paola Cassoni, Sebastian Podlipnik, Cristina Carrera, Sergi Vidal-Sicart, Ramón Pigem, Agustí Toll, Ramón Rull, Llucìa Alos, Celia Requena, Isidro Bolumar, Víctor Traves, Ángel Pla, Almudena Fernández-Orland, Ane Jaka, María Teresa Fernández-Figueras, Nina Anika Richarz, Ricardo Vieira, Rafael Botella-Estrada, Concepción Román-Curto, Lara Ferrándiz-Pulido, Nicolás Iglesias-Pena, Carlos Ferrándiz, Josep Malvehy, Pietro Quaglino, Eduardo Nagore
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/24/5878
_version_ 1797503421293527040
author Antonio Tejera-Vaquerizo
Aram Boada
Simone Ribero
Susana Puig
Sabela Paradela
David Moreno-Ramírez
Javier Cañueto
Blanca de Unamuno-Bustos
Ana Brinca
Miguel A. Descalzo-Gallego
Simona Osella-Abate
Paola Cassoni
Sebastian Podlipnik
Cristina Carrera
Sergi Vidal-Sicart
Ramón Pigem
Agustí Toll
Ramón Rull
Llucìa Alos
Celia Requena
Isidro Bolumar
Víctor Traves
Ángel Pla
Almudena Fernández-Orland
Ane Jaka
María Teresa Fernández-Figueras
Nina Anika Richarz
Ricardo Vieira
Rafael Botella-Estrada
Concepción Román-Curto
Lara Ferrándiz-Pulido
Nicolás Iglesias-Pena
Carlos Ferrándiz
Josep Malvehy
Pietro Quaglino
Eduardo Nagore
author_facet Antonio Tejera-Vaquerizo
Aram Boada
Simone Ribero
Susana Puig
Sabela Paradela
David Moreno-Ramírez
Javier Cañueto
Blanca de Unamuno-Bustos
Ana Brinca
Miguel A. Descalzo-Gallego
Simona Osella-Abate
Paola Cassoni
Sebastian Podlipnik
Cristina Carrera
Sergi Vidal-Sicart
Ramón Pigem
Agustí Toll
Ramón Rull
Llucìa Alos
Celia Requena
Isidro Bolumar
Víctor Traves
Ángel Pla
Almudena Fernández-Orland
Ane Jaka
María Teresa Fernández-Figueras
Nina Anika Richarz
Ricardo Vieira
Rafael Botella-Estrada
Concepción Román-Curto
Lara Ferrándiz-Pulido
Nicolás Iglesias-Pena
Carlos Ferrándiz
Josep Malvehy
Pietro Quaglino
Eduardo Nagore
author_sort Antonio Tejera-Vaquerizo
collection DOAJ
description The therapeutic value of sentinel lymph node biopsy (SLNB) in thin melanoma remains controversial. The aim of this study is to determine the role of SLNB in the survival of thin melanomas (≤1 mm). A multicenter retrospective observational study was designed. A propensity score matching was performed to compare patients who underwent SLNB vs. observation. A multivariate Cox regression was used. A total of 1438 patients were matched by propensity score. There were no significant differences in melanoma-specific survival (MSS) between the SLNB and observation groups. Predictors of MSS in the multivariate model were age, tumor thickness, ulceration, and interferon treatment. Results were similar for disease-free survival and overall survival. The 5- and 10-year MSS rates for SLN-negative and -positive patients were 98.5% vs. 77.3% (<i>p</i> < 0.001) and 97.3% vs. 68.7% (<i>p</i> < 0.001), respectively. SLNB does not improve MSS in patients with thin melanoma. It also had no impact on DSF or OS. However, a considerable difference in MSS, DFS, and OS between SLN-positive and -negative patients exists, confirming its value as a prognostic procedure and therefore we recommend discussing the option of SLNB with patients.
first_indexed 2024-03-10T03:50:23Z
format Article
id doaj.art-0c20589bcade4d6aa15ed09c13d6b449
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T03:50:23Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-0c20589bcade4d6aa15ed09c13d6b4492023-11-23T08:57:32ZengMDPI AGJournal of Clinical Medicine2077-03832021-12-011024587810.3390/jcm10245878Sentinel Lymph Node Biopsy vs. Observation in Thin Melanoma: A Multicenter Propensity Score Matching StudyAntonio Tejera-Vaquerizo0Aram Boada1Simone Ribero2Susana Puig3Sabela Paradela4David Moreno-Ramírez5Javier Cañueto6Blanca de Unamuno-Bustos7Ana Brinca8Miguel A. Descalzo-Gallego9Simona Osella-Abate10Paola Cassoni11Sebastian Podlipnik12Cristina Carrera13Sergi Vidal-Sicart14Ramón Pigem15Agustí Toll16Ramón Rull17Llucìa Alos18Celia Requena19Isidro Bolumar20Víctor Traves21Ángel Pla22Almudena Fernández-Orland23Ane Jaka24María Teresa Fernández-Figueras25Nina Anika Richarz26Ricardo Vieira27Rafael Botella-Estrada28Concepción Román-Curto29Lara Ferrándiz-Pulido30Nicolás Iglesias-Pena31Carlos Ferrándiz32Josep Malvehy33Pietro Quaglino34Eduardo Nagore35Dermatology Department, Instituto Dermatológico GlobalDerm, 14700 Palma del Río, SpainDermatology Department, Hospital Universitari Germans Trials i Pujol, Institut d’Investigació Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916 Badalona, SpainMedical Sciences Department, Section of Dermatology, University of Turin, 10124 Turin, ItalyMelanoma Unit, Dermatology Department, Hospital Clinic, Universitat de Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, SpainDepartamento de Dermatología, Hospital Universitario de la Coruña, 15006 La Coruña, SpainMelanoma Unit, Medical-&-Surgical Dermatology Department, Hospital Universitario Virgen Macarena, 41009 Sevilla, SpainDermatology Department, Complejo Asistencial Universitario de Salamanca, 37007 Salamanca, SpainDermatology Department, Hospital Universitario La Fe, 46126 Valencia, SpainDepartament of Dermatology, University Hospital of Coimbra, 3000-075 Coimbra, PortugalUnidad de Investigación, Fundación Piel Sana, Academia Española de Dermatología, 28008 Madrid, SpainMedical Sciences Department, Section of Surgical Pathology, University of Turin, 10124 Turin, ItalyMedical Sciences Department, Section of Surgical Pathology, University of Turin, 10124 Turin, ItalyMelanoma Unit, Dermatology Department, Hospital Clinic, Universitat de Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, SpainMelanoma Unit, Dermatology Department, Hospital Clinic, Universitat de Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, SpainNuclear Medicine Department, Hospital Clinic Barcelona, Universitat de Barcelona, Institut d’investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, SpainMelanoma Unit, Dermatology Department, Hospital Clinic, Universitat de Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, SpainMelanoma Unit, Dermatology Department, Hospital Clinic, Universitat de Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, SpainSurgery Department, Hospital Clinic, Universidad de Barcelona, 08036 Barcelona, SpainPathology Department, Hospital Clinic, Universidad de Barcelona, 08036 Barcelona, SpainDermatology Department, Instituto Valenciano de Oncología, 46009 Valencia, SpainSurgery Department, Instituto Valenciano de Oncología, 46009 Valencia, SpainPathology Department, Instituto Valenciano de Oncología, 46009 Valencia, SpainOtorhinolaringology Department, Instituto Valenciano de Oncología, 46009 Valencia, SpainMelanoma Unit, Medical-&-Surgical Dermatology Department, Hospital Universitario Virgen Macarena, 41009 Sevilla, SpainDermatology Department, Hospital Universitari Germans Trials i Pujol, Institut d’Investigació Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916 Badalona, SpainPathology Department, Hospital Universitari Germans Trial i Pujol, 08916 Badalona, SpainDermatology Department, Hospital Universitari Germans Trials i Pujol, Institut d’Investigació Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916 Badalona, SpainDepartament of Dermatology, University Hospital of Coimbra, 3000-075 Coimbra, PortugalDermatology Department, Hospital Universitario La Fe, 46126 Valencia, SpainDermatology Department, Complejo Asistencial Universitario de Salamanca, 37007 Salamanca, SpainMelanoma Unit, Medical-&-Surgical Dermatology Department, Hospital Universitario Virgen Macarena, 41009 Sevilla, SpainDepartamento de Dermatología, Hospital Universitario de la Coruña, 15006 La Coruña, SpainDermatology Department, Hospital Universitari Germans Trials i Pujol, Institut d’Investigació Germans Trias i Pujol, Universitat Autònoma de Barcelona, 08916 Badalona, SpainMelanoma Unit, Dermatology Department, Hospital Clinic, Universitat de Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, SpainMedical Sciences Department, Section of Dermatology, University of Turin, 10124 Turin, ItalyDermatology Department, Instituto Valenciano de Oncología, 46009 Valencia, SpainThe therapeutic value of sentinel lymph node biopsy (SLNB) in thin melanoma remains controversial. The aim of this study is to determine the role of SLNB in the survival of thin melanomas (≤1 mm). A multicenter retrospective observational study was designed. A propensity score matching was performed to compare patients who underwent SLNB vs. observation. A multivariate Cox regression was used. A total of 1438 patients were matched by propensity score. There were no significant differences in melanoma-specific survival (MSS) between the SLNB and observation groups. Predictors of MSS in the multivariate model were age, tumor thickness, ulceration, and interferon treatment. Results were similar for disease-free survival and overall survival. The 5- and 10-year MSS rates for SLN-negative and -positive patients were 98.5% vs. 77.3% (<i>p</i> < 0.001) and 97.3% vs. 68.7% (<i>p</i> < 0.001), respectively. SLNB does not improve MSS in patients with thin melanoma. It also had no impact on DSF or OS. However, a considerable difference in MSS, DFS, and OS between SLN-positive and -negative patients exists, confirming its value as a prognostic procedure and therefore we recommend discussing the option of SLNB with patients.https://www.mdpi.com/2077-0383/10/24/5878melanomasentinel lymph node biopsysurvival
spellingShingle Antonio Tejera-Vaquerizo
Aram Boada
Simone Ribero
Susana Puig
Sabela Paradela
David Moreno-Ramírez
Javier Cañueto
Blanca de Unamuno-Bustos
Ana Brinca
Miguel A. Descalzo-Gallego
Simona Osella-Abate
Paola Cassoni
Sebastian Podlipnik
Cristina Carrera
Sergi Vidal-Sicart
Ramón Pigem
Agustí Toll
Ramón Rull
Llucìa Alos
Celia Requena
Isidro Bolumar
Víctor Traves
Ángel Pla
Almudena Fernández-Orland
Ane Jaka
María Teresa Fernández-Figueras
Nina Anika Richarz
Ricardo Vieira
Rafael Botella-Estrada
Concepción Román-Curto
Lara Ferrándiz-Pulido
Nicolás Iglesias-Pena
Carlos Ferrándiz
Josep Malvehy
Pietro Quaglino
Eduardo Nagore
Sentinel Lymph Node Biopsy vs. Observation in Thin Melanoma: A Multicenter Propensity Score Matching Study
Journal of Clinical Medicine
melanoma
sentinel lymph node biopsy
survival
title Sentinel Lymph Node Biopsy vs. Observation in Thin Melanoma: A Multicenter Propensity Score Matching Study
title_full Sentinel Lymph Node Biopsy vs. Observation in Thin Melanoma: A Multicenter Propensity Score Matching Study
title_fullStr Sentinel Lymph Node Biopsy vs. Observation in Thin Melanoma: A Multicenter Propensity Score Matching Study
title_full_unstemmed Sentinel Lymph Node Biopsy vs. Observation in Thin Melanoma: A Multicenter Propensity Score Matching Study
title_short Sentinel Lymph Node Biopsy vs. Observation in Thin Melanoma: A Multicenter Propensity Score Matching Study
title_sort sentinel lymph node biopsy vs observation in thin melanoma a multicenter propensity score matching study
topic melanoma
sentinel lymph node biopsy
survival
url https://www.mdpi.com/2077-0383/10/24/5878
work_keys_str_mv AT antoniotejeravaquerizo sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT aramboada sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT simoneribero sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT susanapuig sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT sabelaparadela sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT davidmorenoramirez sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT javiercanueto sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT blancadeunamunobustos sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT anabrinca sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT migueladescalzogallego sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT simonaosellaabate sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT paolacassoni sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT sebastianpodlipnik sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT cristinacarrera sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT sergividalsicart sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT ramonpigem sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT agustitoll sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT ramonrull sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT lluciaalos sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT celiarequena sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT isidrobolumar sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT victortraves sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT angelpla sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT almudenafernandezorland sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT anejaka sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT mariateresafernandezfigueras sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT ninaanikaricharz sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT ricardovieira sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT rafaelbotellaestrada sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT concepcionromancurto sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT laraferrandizpulido sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT nicolasiglesiaspena sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT carlosferrandiz sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT josepmalvehy sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT pietroquaglino sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy
AT eduardonagore sentinellymphnodebiopsyvsobservationinthinmelanomaamulticenterpropensityscorematchingstudy